Makati City Bakuna
Advertisement

Pharmally and Duterte’s love

"That is what I call a fast buck."

 

Revelations at the recent hearings of the Senate anti-graft probe body, the Blue Ribbon committee, revealed how the Duterte government coddled the once unknown and struggling Pharmally Pharmaceutical Corp., a Chinese-owned company, in securing over P9 billion in choice contracts for the supply of anti-COVID paraphernalia—face masks, face shields, RT-PCR tests, and PPE sets (protective uniforms for health personnel), between March 25, 2020 and June 2, 2021.

Incorporated only in September 2019, Pharmally is a company with barely P600,000 in startup capital and in 2019 even reported a loss.

It has a powerful backer, billionaire Michael Yang, a Davao-based Chinese, and a former economic adviser to President Duterte.

In one strange contract, for the supply of 500,000 pieces of face masks for P8 million, Pharmally was asked, by email by the cabinet-level Department of the Budget and Management, to quote a price on March 25, 2020.  Instead of just quoting a price, Pharmally proceeded to deliver the 500,000 face masks to the Procurement Service of the Department of Budget and Management (PS-DBM)—on March 25, 2020, the same day.

Pharmally got paid promptly, for a higher amount, P12.8 million, on April 15, 2020. The actual PS-DBM purchase order (PO), dated April 6, 2020, arrived on April 16, 2020, three weeks after the delivery of the goods being ordered. That is what I call a fast buck.

Outrageous is the fact that Pharmally did not even have the inventory of the 500,000 face masks, nor did it have the warehouse to store the masks. A Pharmally director, Lincoln Ong, simply called up another local supplier or a “contact,” a Tiger Phil Marketing, headed by a “brother Tiger,” to provide the 500,000 face masks. Pharmally contracted another warehouse for the purpose. Obviously, with P600,000 startup capital, Pharmally cannot afford to keep inventory of supplies worth billions nor build warehouses for them.

Were the face masks actually delivered? Nobody knows for sure. “I suspect it is a ghost delivery,” surmises Senator Frank Drilon. The view is shared by Blue Ribbon chairman Senator Richard Gordon.

What is sure is that the government bought the face masks at a huge overprice, P27.72 per piece. At that time, March 2020, you could buy face masks, at lower volumes, for P5 to P13.50 per piece. Pharmally’s Ong claims he bought the face masks from Tiger Phil for P23 a piece.

On April 14, 2020, Pharmally also was asked to quote a price for 2.4 million pieces of surgical masks. The same day, April 14, 2020, the company got the contract, worth P54 million, for 2.4 million pieces of masks, at P22.50 per piece.

During April 2020 alone, Pharmally got four contracts totaling nearly P10 billion. These include the 2.4 million pieces of surgical masks worth P54 million, 4.5 million pieces of surgical masks worth P220 million, 2,000 RT-PCR test kits worth P688 million, and infrared thermometers, goggles and face shields worth P619,200.

Overall, Pharmally’s five biggest contracts, so far, are: P3.82 billion for two million sets of PPEs on May 8, 2020; P2.88 billion for 41,400 RT-PCR test kits, on June 9, 2020; P774.35 million for 17,000 RT-PCR test kits on June 2, 2021; P688 million for 2,000 RT-PCR test kits: and P220 million for 4.5 million pieces of surgical masks.

Compare that VIP treatment given Pharmally to the shabby deal dealt a Filipino company, EMS Components Assembly headed by Ferdinand Ferrer.

Ferrer won the bid to supply 100 million face masks for only P13.50, or P1.35 billion. He invested P250 million in his plant to supply the face masks. When the masks were ready for delivery, PS-DBM told EMS to hold the delivery.

By the time PS-DBM was ready to accept the masks, it told EMS to reduce the price drastically, to P2.35 per piece only. Ferrer lost money, badly, in the deal. This is a company who put up a factory, could produce the pieces, could deliver them on time and had the warehouse space for them.

Pharmally did not manufacture the billions-worth supplies it was selling to the government, got the contracts on the same dates it was asked to make a quote in apparent concession to bidding procedure, and got paid in advance even before it could receive the actual purchase order.

Now, I ask you, a la Pulse Asia: Do you approve of the way Duterte does his job? Do you trust him?

In December, 91 percent said yes to both questions. Today, unfortunately, there has been no new surveys on Duterte’s job approval and trust ratings.  Meantime, lab talaga ni Digong Duterte mga Chinese, Michael Yang and Pharmally, included.

[email protected]

Topics: Tony Lopez , Senate , the Blue Ribbon committee , Pharmally Pharmaceutical Corp. ,
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.
AdvertisementSpeaker GMA
Reopening: PH Economy on The Mend
Advertisement
Reopening: PH Economy on The Mend